| ELANCO ANIMAL HEALTH. |
| USA |
| Gesundheit |
| US28414H1032 / A2N6BH |
| 5EA (Frankfurt) / ELAN (NYSE) |
| FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN |
| - |
| https://www.elanco.com/ |
|
Elanco Animal Health Incorporated is a leading global pharmaceutical company specializing in animal health. Its primary function is the development and delivery of innovative products and solutions to..
>Volltext.. |
| 10367.81 Mio. EUR |
| 13370.25 Mio. EUR |
| 3858.16 Mio. EUR |
| 765.58 Mio. EUR |
| 30.25 Mio. EUR |
| 0.06 EUR |
| 3381.67 Mio. EUR |
| 424.39 Mio. EUR |
| 528.6 Mio. EUR |
| 0.35 |
| -2.2% |
| -83.34% |
| - |
| - |
| - |
| - |
| ELANCO |
| 13.02.26 |
|